SCHEMBL6453906

SCHEMBL6453906

CC(C)(c1nc(-c2ccccc2)cs1)c1c(Cl)cc(N/N=C(\C#N)C(=O)NC(=O)O)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RAPGEF3 O95398 11/20 0.39
RAPGEF4 Q8WZA2 3/20 0.39
MAPT P10636 4/20 0.39
MAPK1 P28482 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
ALOX12 P18054 2/20 0.38
MRE11 P49959 1/20 0.36
HTT P42858 2/20 0.36
NPY1R P25929 1/20 0.35
NPY2R P49146 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6453911 1.00 RAPGEF3 (0.39) RAPGEF3RAPGEF4MAPTMAPK1MEN1
SCHEMBL7887153 0.80 MRE11 (0.40) RAPGEF3RAPGEF4MAPTMAPK1MEN1
SCHEMBL7887157 0.80 MRE11 (0.39) RAPGEF3RAPGEF4MAPTMAPK1MEN1
SCHEMBL6465506 0.77 MEN1 (0.48) MAPTMAPK1MEN1KMT2ALMNA
SCHEMBL10421616 0.72 ALOX12 (0.50) RAPGEF3RAPGEF4MAPTMEN1KMT2A
SCHEMBL10421615 0.72 ALOX12 (0.50) RAPGEF3RAPGEF4MAPTMEN1KMT2A
SCHEMBL6455740 0.71 ALDH1A1 (0.46) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL22632458 0.71 MEN1 (0.48) RAPGEF3RAPGEF4MAPTMEN1KMT2A
SCHEMBL22632459 0.71 MEN1 (0.48) RAPGEF3RAPGEF4MAPTMEN1KMT2A
SCHEMBL10421664 0.70 ALOX12 (0.48) RAPGEF3RAPGEF4MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6894046-B2 IL-5 inhibiting 6-azauracil derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2005-05-17 US disclosed
EP-1114046-B1 INTERLEUKIN-5 INHIBITING 6-AZAURACIL DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2003-04-23 EP disclosed
EP-0987265-A1 Interleukin-5 inhibiting 6-azauracil derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2000-03-22 EP disclosed